These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7207081)

  • 1. Medical costs and the drug industry.
    Schwartz H
    Med Times; 1981 Mar; 109(3):21s-24s, 28s. PubMed ID: 7207081
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical costs and the drug industry.
    Schwartz H
    Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744
    [No Abstract]   [Full Text] [Related]  

  • 3. Costs of submitting an IND and obtaining an effective NDA for a new oral drug.
    Elvers WB
    Pharmacol Ther Dent; 1971 Feb; 1(2):102-10. PubMed ID: 5293558
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoeconomics: determining the value of drug therapy.
    Peterson C
    Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751
    [No Abstract]   [Full Text] [Related]  

  • 5. The medicolegal aspects of adverse drug reactions.
    Bernstein HN; Levine AM
    Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801
    [No Abstract]   [Full Text] [Related]  

  • 6. Dr. Goddard and the PMA.
    Rev Allergy; 1969 Mar; 23(3):161-3. PubMed ID: 5786222
    [No Abstract]   [Full Text] [Related]  

  • 7. How effective are medicines in containing health-care costs?
    Pharm Times; 1982 Aug; 48(8):38-40. PubMed ID: 10257236
    [No Abstract]   [Full Text] [Related]  

  • 8. American Academy of Pediatrics Committee on Drugs. "Therapeutic orphans" and the package insert.
    Pediatrics; 1970 Nov; 46(5):811-3. PubMed ID: 5536437
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Now it's their turn'.
    Silverman M
    J Am Pharm Assoc; 1971 Jul; 11(7):374-5 passim. PubMed ID: 5142131
    [No Abstract]   [Full Text] [Related]  

  • 10. Rising costs hold up drug discovery.
    Miller HI
    Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic freedom.
    Trout ME
    J Leg Med (N Y); 1974; 2(5):40-2. PubMed ID: 4548704
    [No Abstract]   [Full Text] [Related]  

  • 12. On the "costs" of the 1962 drug amendments.
    Smith MC; Visconti JA
    Inquiry; 1974 Mar; 11(1):61-4. PubMed ID: 4274295
    [No Abstract]   [Full Text] [Related]  

  • 13. Food and Drug Administration. Tempest over polio vaccine.
    Anderson C
    Nature; 1991 Jun; 351(6327):510. PubMed ID: 2046758
    [No Abstract]   [Full Text] [Related]  

  • 14. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 15. Should off-label drug use be off-the-table?
    Rivkees SA
    J Pediatr Endocrinol Metab; 2007 Feb; 20(2):171-2. PubMed ID: 17396432
    [No Abstract]   [Full Text] [Related]  

  • 16. [The heavily increasing costs of drugs].
    Kampmann JP
    Ugeskr Laeger; 1989 Apr; 151(14):905-7. PubMed ID: 2711502
    [No Abstract]   [Full Text] [Related]  

  • 17. A prescription for better prescriptions.
    Woosley RL
    Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
    [No Abstract]   [Full Text] [Related]  

  • 18. Who pays what in drug development.
    Love J
    Nature; 1999 Jan; 397(6716):202. PubMed ID: 9930689
    [No Abstract]   [Full Text] [Related]  

  • 19. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 20. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.